Budesonide/glycopyrronium/formoterol fumarate triple therapy prevents pulmonary hypertension in a COPD mouse model via NFκB inactivation

RT @AlphaCopdDoc: This would be interesting but challenging to study in vivo. Particularly interesting for patients where PH disproportiona…

This would be interesting but challenging to study in vivo. Particularly interesting for patients where PH disproportionate to #copd or triple rx not otherwise indicated

RT @RespiratoryBMC: Budesonide/glycopyrronium/formoterol fumarate triple therapy prevents pulmonary hypertension in a #COPD mouse model via…

RT @RespiratoryBMC: Budesonide/glycopyrronium/formoterol fumarate triple therapy prevents pulmonary hypertension in a #COPD mouse model via…